All Curated Mutation Sites in TBEV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in TBEV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
E
  
NS1
  
NS3
  
NS4B
  
NS5
  
C
  

Keyword: Cell line-24808743
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 24808743 E122G
E
envelope
Cell line
G
R
View
2 24808743 A1342G
E
envelope
Cell line
G
R
View
3 24808743 G101G
E
envelope
Cell line
G
R
View
4 24808743 T1277G
E
envelope
Cell line
G
R
View
5 24808743 G148G
E
envelope
Cell line
G
R
View
6 24808743 G1415T
E
envelope
Cell line
G
R
View
7 24808743 G191G
E
envelope
Cell line
G
R
View
8 24808743 T1544C
E
envelope
Cell line
G
R
View
9 24808743 L224L
E
envelope
Cell line
G
R
View
10 24808743 C1644T
E
envelope
Cell line
G
R
View
11 24808743 S425S
NS1
NS1
Cell line
G
R
View
12 24808743 T2246C
NS1
NS1
Cell line
G
R
View
13 24808743 E36V
NS1
NS1
Cell line
G
R
View
14 24808743 A2569T
NS1
NS1
Cell line
G
R
View
15 24808743 P130P
NS1
NS1
Cell line
G
R
View
16 24808743 A2894G
NS1
NS1
Cell line
G
R
View
17 24808743 S338F
NS3
NS3
Cell line
G
R
View
18 24808743 C5614T
NS3
NS3
Cell line
G
R
View
19 24808743 D344Y
NS3
NS3
Cell line
G
R
View
20 24808743 G5652T
NS3
NS3
Cell line
G
R
View
21 24808743 V149A
prM
prM
Cell line
G
R
View
22 24808743 T149C
prM
prM
Cell line
G
R
View
Contents
Description

The table shows all curated mutation sites of TBEV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.